Valley Brook Capital Group, Inc. Merck & Co., Inc. Transaction History
Valley Brook Capital Group, Inc.
- $139 Million
- Q3 2024
A detailed history of Valley Brook Capital Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Valley Brook Capital Group, Inc. holds 7,632 shares of MRK stock, worth $743,662. This represents 0.62% of its overall portfolio holdings.
Number of Shares
7,632
Previous 7,607
0.33%
Holding current value
$743,662
Previous $941,000
7.97%
% of portfolio
0.62%
Previous 0.73%
Shares
15 transactions
Others Institutions Holding MRK
# of Institutions
3,819Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.3 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.6 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.39 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.76 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $247B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...